NCT02162784 - Efficacy Study of SYN006 HFA MDI in Asthma Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Asthma

Interventions

DRUG

Budesonide/Procaterol, 180/10mcg X1

one puff

DRUG

Budesonide/procaterol 180/10 mcg X 2

2 puffs

DRUG

Albuterol HFA MDI 100mcg X2

HFA MDI, 100mcg, 2 puffs

Trial Locations (3)

Chung Shan Medical University Hospital, Taichung

National Taiwan University Hospital, Taipei

Tri-Service General Hospital, Taipei